Peter Turvey

Peter Turvey spent over 28 years being involved in the biotechnology industry, most of which were as general counsel and company secretary in Australia’s largest biotechnology company CSL Limited. Mr Turvey was heavily involved in CSL’s acquisitions and divestments, and was directly responsible for the protection and licensing of its intellectual property.

Lists and Charts

Share Transactions

04/11/20

$20k Bought

Starpharma Holdings

05/02/16

$0 Other

Admedus

05/02/16

$0 Other

Admedus

Total value as at the date of the transaction

Related Information

Positions - Previous

Position	Company	Year
Non-Executive Director	Starpharma Holdings	2012 - 2021
Non-Executive Director	Viralytics	2014 - 2018
Non-Executive Director	Admedus	2012 - 2016
Non-Executive Director	Anteris Technologies	- 2016
Non-Executive Director	Admedus	2012 - 2016
Group General Counsel, Company Secretary	CSL	1998 - 2009

Directors Interests

Company	Date	Transaction type	Number of shares	Price per share	Transaction value	Nature of change
Starpharma Holdings	04 Nov 2020	Bought	13,334	$1.50	$20,000	OtherParticipation in share purchase plan
Admedus	05 Feb 2016	Other	274,255			OtherOff-market transfer: Assumed 274,255 Indirect Shares transferred to Direct Shares.
Admedus	05 Feb 2016	Other	274,255			OtherOff-market transfer: Assumed 274,255 Indirect Shares transferred to Direct Shares.
Admedus	10 Dec 2015	Issued	19,036	$0.81	$15,400	OtherDirector remuneration
Admedus	10 Dec 2015	Other	317,204			OtherOff-market transfer: Assumed 317,204 Direct Shares transferred to Indirect Shares.

View All

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options